Investment Summary

Baird Capital, Accelmed and Palisades Growth Capital Invest In AiCure

On November 17, 2017, private equity firm Baird Capital, private equity firm Accelmed and growth capital firm Palisades Growth Capital invested in information technology company AiCure

Investment Highlights
  • This is Baird Capital’s 5th, Accelmed’s 1st and Palisades Growth Capital’s 2nd transaction in the Information Technology sector.
  • This is Baird Capital’s 49th, Accelmed’s 2nd and Palisades Growth Capital’s 9th transaction in the United States.
  • This is Baird Capital’s 3rd, Accelmed’s 1st and Palisades Growth Capital’s 3rd transaction in New York.

Investment Summary

Date 2017-11-17
Target AiCure
Sector Information Technology
Investor(s) Baird Capital
Accelmed
Palisades Growth Capital
Deal Type Venture

Target

AiCure

New York, New York, United States
AiCure is a provider of data analytics targeting the healthcare industry. AiCure software captures and understands video, audio, and behavioral data to establish the link between patients, disease, and treatment. AiCure was founded in 2010 and is based in New York, New York.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 3

Investor

Baird Capital

Chicago, Illinois, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1989
PE ASSETS 3.1B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Baird Capital Partners (BCP) is the US private equity arm of Baird Private Equity. BCP makes investments in middle-market companies based in the US. BCP targets companies valued between $25 and $125 million and looks to invest between $15 and $35 million of equity per transaction. BCP focuses on three primary areas including business services (transaction processing, process outsourcing, professional services), healthcare (outsourcing services, medical products, contract manufacturing), and manufactured products (industrial/commercial, specialty consumer, distribution). BCP is affiliated with Baird Capital Partners Europe, Baird Capital Partners Asia, Baird Venture Partners, and Granville Baird Capital Partners. Baird Capital Partners is based in Chicago, Illinois.


DEAL STATS #
Overall 58 of 76
Sector: Information Technology M&A 5 of 8
Type: Venture M&A Deals 3 of 10
State: New York M&A 3 of 3
Country: United States M&A 49 of 63
Year: 2017 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-11-15 Hopebridge

Kokomo, Indiana, United States

Hopebridge provides personalized, comprehensive outpatient Applied Behavior Analysis (ABA), occupational, speech, and feeding therapies for children with an autism spectrum disorder or affected by other behavioral, physical, social, communication, and sensory challenges. Hopebridge was founded in 2005 and is based in Kokomo, Indiana.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-05 Collage

Paoli, Pennsylvania, United States

Collage is a provider of treatment for individuals with traumatic brain injuries (TBI) and number one in the Mid-Atlantic market. Collage extensive continuum of care allows access at varying levels and stages of recovery, whether the injury is mild, moderate or severe. Collage was founded in 1984 and is based in Paoli, Pennsylvania.

Buy -
Investor
DESCRIPTION

Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues between $20 and $70 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in Miami, Florida.


DEAL STATS #
Overall 4 of 18
Sector: Information Technology M&A 1 of 2
Type: Venture M&A Deals 3 of 8
State: New York M&A 1 of 3
Country: United States M&A 2 of 14
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-01 Digma Medical

Givat Shmuel, Israel

Digma Medical is the developer of a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels in patients with Type 2 diabetes. Digma Medical was founded in 2013 and is based in Givat Shmuel, Israel.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-03-16 Nitinotes

Caesarea, Israel

Nitinotes is the developer of a minimally-invasive suturing system intended for safer, simpler gastrointestinal suturing. Nitinotes was founded in 2014 and is based in Caesarea, Israel.

Buy -
DESCRIPTION

Palisades Growth Capital makes growth stage investments in technology, media, telecommunications, and business services companies. The Firm prefers companies headquartered in Southern California and seeks to invest $5 to $25million per transaction. Target companies generally have $5 to $25 million in revenue. Palisades Growth Capital was established in 2001 and is headquartered in Los Angeles.


DEAL STATS #
Overall 9 of 13
Sector: Information Technology M&A 2 of 2
Type: Venture M&A Deals 8 of 11
State: New York M&A 3 of 4
Country: United States M&A 9 of 13
Year: 2017 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-11-06 QLess

Pasadena, California, United States

QLess is an operator of queue management and customer experience platform. QLess’s mobile queuing solutions are used around the world in more than 1000 locations to save customers time and improve business productivity. QLess was founded in 2007 and is based in Pasadena, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-25 Zeel

New York, New York, United States

Zeel is a cloud based on-demand massage app with more than 6,000 licensed massage therapists in its network. Zeel offers the most reliable on-demand massage service in as little as an hour, or up to a month in advance, seven days a week, 365 days a year, with start times as early as 8am and as late as 10:30pm. Zeel was founded in 2010 and is based in New York, New York.

Buy -